Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size, Status and Forecast 2018-2025 _x000D_

    Report ID : 70683   |  Published On: October 2018 |   Pages:97_x000D_ |   Format:PDF

This report studies the Amyotrophic Lateral Sclerosis (ALS) Treatment market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top company in global and major regions, and splits the Amyotrophic Lateral Sclerosis (ALS) Treatment market by product type and applications/end industries. In the last several years, global market of Amyotrophic Lateral Sclerosis (ALS) Treatment developed smoothly, with an average growth rate of 21% during 2013 to 2018. The principal reason was contribution made by Radicava, which was launched in the USA in August 2017. And Radicava has gotten off to a strong start. In 2017, global revenue of Amyotrophic Lateral Sclerosis (ALS) Treatment is nearly 197 million USD. The major players in global Amyotrophic Lateral Sclerosis (ALS) Treatment market include Mitsubishi Tanabe Pharma Sanofi Mylan Pharma Apotex Glemark Generics Covis Pharma Sun Pharma Lunan Pharma Geographically, this report is segmented into several key regions, with production, sales, revenue, market share and growth rate of Amyotrophic Lateral Sclerosis (ALS) Treatment in these regions, from 2013 to 2025 (forecast), covering North America Europe China Japan Southeast Asia India South America Rest of World On the basis of product, the Amyotrophic Lateral Sclerosis (ALS) Treatment market is primarily split into Riluzole Edaravone (Radicava) Other On the basis on the end users/applications, this report covers Hospital Drugs Store Other

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents 1 Report Overview 1 1.1 Study Scope 1 1.2 Key Market Segments 1 1.3 Players Covered 2 1.4 Market Analysis by Type 2 1.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Type (2013-2025) 2 1.4.2 Riluzole 3 1.4.3 Edaravone (Radicava) 4 1.5 Market by Application 4 1.6 Study Objectives 4 1.7 Years Considered 5 2 Global Growth Trends 6 2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 6 2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Growth Trends by Regions 7 2.2.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions (2013-2025) 7 2.2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions (2013-2018) 7 2.3 Industry Trends 9 2.3.1 Market Top Trends 9 2.3.2 Market Drivers 10 2.3.3 Market Opportunities 10 3 Market Share by Key Players 20 3.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Manufacturers 20 3.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Manufacturers (2017-2018) 20 3.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Manufacturers (2017-2018) 20 3.1.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Concentration Ratio (CR5) 23 3.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players Head office and Area Served 23 3.3 Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Product/Solution/Service 24 3.4 Date of Enter into Amyotrophic Lateral Sclerosis (ALS) Treatment Market 24 3.5 Mergers & Acquisitions, Expansion Plans 24 4 Breakdown Data by Type and Application 27 4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) 27 4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) 28 5 North America 30 5.1 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018) 30 5.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in North America 30 5.3 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type 31 5.4 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application 32 6 Europe 33 6.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018) 33 6.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in Europe 33 6.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type 34 6.4 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application 35 7 China 36 7.1 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018) 36 7.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in China 36 7.3 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type 37 7.4 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application 38 8 Japan 39 8.1 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018) 39 8.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in Japan 39 8.3 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type 40 8.4 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application 41 9 Southeast Asia 42 9.1 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018) 42 9.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in Southeast Asia 42 9.3 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type 43 9.4 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application 44 10 India 45 10.1 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018) 45 10.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in India 45 10.3 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type 46 10.4 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application 47 11 South America 48 11.1 South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018) 48 11.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in South America 48 11.3 South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type 49 11.4 South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application 50 12 Analysis of Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Key Manufacturers 51 12.1 Mitsubishi Tanabe Pharma 51 12.1.1 Company Profile 51 12.1.2 Product Information 52 12.1.3 Revenue and Gross Margin 52 12.2 Sanofi 53 12.2.1 Company Profile 53 12.2.2 Product Information 54 12.2.3 Revenue and Gross Margin 54 12.3 Mylan Pharma 55 12.3.1 Company Profile 55 12.3.2 Product Information 56 12.3.3 Revenue and Gross Margin 56 12.4 Apotex 57 12.4.1 Company Profile 57 12.4.2 Product Information 58 12.4.3 Revenue and Gross Margin 58 12.5 Glemark Generics 59 12.5.1 Company Profile 59 12.5.2 Product Information 60 12.5.3 Revenue and Gross Margin 60 12.6 Covis Pharma 61 12.6.1 Company Profile 61 12.6.2 Product Information 62 12.6.3 Revenue and Gross Margin 62 12.7 Sun Pharma 62 12.7.1 Company Profile 62 12.7.2 Product Information 64 12.7.3 Revenue and Gross Margin 64 12.8 Lunan Pharma 64 12.8.1 Company Profile 64 12.8.2 Product Information 66 12.8.3 Revenue and Gross Margin 66 13 Market Forecast 2019-2025 67 13.1 Market Size Forecast by Regions 67 13.2 North America 68 13.3 Europe 69 13.4 China 70 13.5 Japan 71 13.6 Southeast Asia 72 13.7 India 73 13.8 South America 74 13.9 Market Size Forecast by Product (2019-2025) 74 13.10 Market Size Forecast by Application (2019-2025) 76 14 Analyst's Viewpoints/Conclusions 78 15 Appendix 79 15.1 Research Methodology 79 15.1.1 Methodology/Research Approach 79 15.1.2 Data Source 83 15.2 Disclaimer 84 15.3 Author Details 85 List of Table and Figure Table Amyotrophic Lateral Sclerosis (ALS) Treatment Key Market Segments 1 Table Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Covered 2 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Type (2013-2025) (M USD) 2 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type in 2018 3 Figure Riluzole Features 3 Table of Key Players of Riluzole 3 Figure Edaravone (Radicava) Features 4 Table of Key Players of Edaravone (Radicava) 4 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth by Application (2013-2025) (M USD) 4 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Report Years Considered 5 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size and Growth Rate 2013-2025 (M USD) 6 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions 2013-2025 (M USD) 7 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions 2013-2018 (M USD) 7 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions 2013-2018 8 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions 2013-2018 8 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions 2018 9 Table Market Drivers 10 Figure Global GDP Growth Rate for 2016 11 Figure Real GDP Growth 2016-2020 Annual Average 12 Figure USA GDP 2008-2016 (Billion USD) 13 Figure USA GDP Growth Rate Change 2015-2018 13 Figure EU GDP 2008-2016 (Billion USD) 14 Figure EU GDP Growth Rate Change 2015-2018 14 Figure Germany GDP 2008-2016 (Billion USD) 15 Figure Germany GDP Growth Rate 2015-2018 15 Figure UK GDP 2008-2016 (Billion USD) 15 Figure UK GDP Growth Rate 2015-2018 16 Figure Italy GDP 2008-2016 (Billion USD) 16 Figure Italy GDP Growth Rate 2015-2018 16 Figure France GDP 2008-2016 (Billion USD) 17 Figure France GDP Growth Rate 2015-2018 17 Figure Japan GDP 2008-2016 (Billion USD) 17 Figure Japan GDP Growth Rate 2015-2018 18 Figure China GDP 2008-2016 (Billion USD) 18 Figure China GDP Growth Rate 2015-2018 18 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Manufacturers (2017-2018) (M USD) 20 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Manufacturers (2017-2018) 20 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Manufacturers in 2017 21 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Manufacturers in 2018 22 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Manufacturers Market Concentration Ratio (CR5) 23 Table Key Players Head office and Area Served 23 Table Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Product/Solution/Service 24 Table Date of Enter into Amyotrophic Lateral Sclerosis (ALS) Treatment Market 24 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD) 27 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Type (2013-2018) 27 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2013-2018) 28 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD) 28 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Application (2013-2018) 28 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2013-2018) 29 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Application in 2018 29 Figure North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD) 30 Table North America Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD) 30 Table North America Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018) 31 Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD) 31 Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018) 31 Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD) 32 Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018) 32 Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD) 33 Table Europe Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD) 33 Table Europe Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018) 34 Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD) 34 Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018) 34 Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD) 35 Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018) 35 Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD) 36 Table China Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD) 36 Table China Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018) 37 Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD) 37 Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018) 37 Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD) 38 Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018) 38 Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD) 39 Table Japan Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD) 39 Table Japan Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018) 40 Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD) 40 Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018) 40 Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD) 41 Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018) 41 Figure Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD) 42 Table Southeast Asia Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD) 42 Table Southeast Asia Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018) 43 Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD) 43 Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018) 43 Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD) 44 Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018) 44 Figure India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD) 45 Table India Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD) 45 Table India Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018) 46 Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD) 46 Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018) 46 Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD) 47 Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018) 47 Figure South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD) 48 Table South America Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD) 48 Table South America Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018) 49 Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD) 49 Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018) 49 Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD) 50 Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018) 50 Table Mitsubishi Tanabe Pharma Company Profile 51 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Mitsubishi Tanabe Pharma 52 Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Mitsubishi Tanabe Pharma 2017-2018 52 Table Sanofi Company Profile 53 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Sanofi 54 Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Sanofi 2017-2018 54 Table Mylan Pharma Company Profile 55 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Mylan Pharma 56 Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Mylan Pharma 2017-2018 56 Table Apotex Company Profile 57 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Apotex 58 Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Apotex 2017-2018 58 Table Glemark Generics Company Profile 59 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Glemark Generics 60 Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Glemark Generics 2017-2018 60 Table Covis Pharma Company Profile 61 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Covis Pharma 62 Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Covis Pharma 2017-2018 62 Table Sun Pharma Company Profile 62 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Sun Pharma 64 Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Sun Pharma 2017-2018 64 Table Lunan Pharma Company Profile 64 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Lunan Pharma 66 Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Lunan Pharma 2017-2018 66 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions (M USD) 2019-2025 67 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Regions (2019-2025) 67 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Regions in 2025 68 Figure North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast (2019-2025) (M USD) 68 Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast (2019-2025) (M USD) 69 Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast (2019-2025) (M USD) 70 Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast (2019-2025) (M USD) 71 Figure Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast (2019-2025) (M USD) 72 Figure India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast (2019-2025) (M USD) 73 Figure South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast (2019-2025) (M USD) 74 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Product (2019-2025) (M USD) 74 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Product (2019-2025) 75 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Product in 2025 75 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2019-2025) (M USD) 76 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2019-2025) 76 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application in 2025 77 Table Research Programs/Design for This Report 79 Figure Bottom-up and Top-down Approaches for This Report 81 Figure Data Triangulation 82 Table Key Data Information from Secondary Sources 83 Table Key Data Information from Primary Sources 84  
Table and Figure Table Amyotrophic Lateral Sclerosis (ALS) Treatment Key Market Segments 1 Table Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Covered 2 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Type (2013-2025) (M USD) 2 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type in 2018 3 Figure Riluzole Features 3 Table of Key Players of Riluzole 3 Figure Edaravone (Radicava) Features 4 Table of Key Players of Edaravone (Radicava) 4 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth by Application (2013-2025) (M USD) 4 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Report Years Considered 5 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size and Growth Rate 2013-2025 (M USD) 6 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions 2013-2025 (M USD) 7 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions 2013-2018 (M USD) 7 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions 2013-2018 8 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions 2013-2018 8 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions 2018 9 Table Market Drivers 10 Figure Global GDP Growth Rate for 2016 11 Figure Real GDP Growth 2016-2020 Annual Average 12 Figure USA GDP 2008-2016 (Billion USD) 13 Figure USA GDP Growth Rate Change 2015-2018 13 Figure EU GDP 2008-2016 (Billion USD) 14 Figure EU GDP Growth Rate Change 2015-2018 14 Figure Germany GDP 2008-2016 (Billion USD) 15 Figure Germany GDP Growth Rate 2015-2018 15 Figure UK GDP 2008-2016 (Billion USD) 15 Figure UK GDP Growth Rate 2015-2018 16 Figure Italy GDP 2008-2016 (Billion USD) 16 Figure Italy GDP Growth Rate 2015-2018 16 Figure France GDP 2008-2016 (Billion USD) 17 Figure France GDP Growth Rate 2015-2018 17 Figure Japan GDP 2008-2016 (Billion USD) 17 Figure Japan GDP Growth Rate 2015-2018 18 Figure China GDP 2008-2016 (Billion USD) 18 Figure China GDP Growth Rate 2015-2018 18 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Manufacturers (2017-2018) (M USD) 20 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Manufacturers (2017-2018) 20 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Manufacturers in 2017 21 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Manufacturers in 2018 22 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Manufacturers Market Concentration Ratio (CR5) 23 Table Key Players Head office and Area Served 23 Table Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Product/Solution/Service 24 Table Date of Enter into Amyotrophic Lateral Sclerosis (ALS) Treatment Market 24 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD) 27 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Type (2013-2018) 27 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2013-2018) 28 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD) 28 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Application (2013-2018) 28 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2013-2018) 29 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Application in 2018 29 Figure North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD) 30 Table North America Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD) 30 Table North America Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018) 31 Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD) 31 Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018) 31 Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD) 32 Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018) 32 Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD) 33 Table Europe Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD) 33 Table Europe Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018) 34 Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD) 34 Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018) 34 Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD) 35 Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018) 35 Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD) 36 Table China Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD) 36 Table China Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018) 37 Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD) 37 Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018) 37 Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD) 38 Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018) 38 Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD) 39 Table Japan Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD) 39 Table Japan Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018) 40 Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD) 40 Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018) 40 Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD) 41 Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018) 41 Figure Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD) 42 Table Southeast Asia Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD) 42 Table Southeast Asia Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018) 43 Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD) 43 Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018) 43 Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD) 44 Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018) 44 Figure India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD) 45 Table India Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD) 45 Table India Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018) 46 Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD) 46 Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018) 46 Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD) 47 Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018) 47 Figure South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD) 48 Table South America Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD) 48 Table South America Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018) 49 Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD) 49 Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018) 49 Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD) 50 Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018) 50 Table Mitsubishi Tanabe Pharma Company Profile 51 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Mitsubishi Tanabe Pharma 52 Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Mitsubishi Tanabe Pharma 2017-2018 52 Table Sanofi Company Profile 53 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Sanofi 54 Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Sanofi 2017-2018 54 Table Mylan Pharma Company Profile 55 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Mylan Pharma 56 Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Mylan Pharma 2017-2018 56 Table Apotex Company Profile 57 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Apotex 58 Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Apotex 2017-2018 58 Table Glemark Generics Company Profile 59 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Glemark Generics 60 Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Glemark Generics 2017-2018 60 Table Covis Pharma Company Profile 61 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Covis Pharma 62 Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Covis Pharma 2017-2018 62 Table Sun Pharma Company Profile 62 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Sun Pharma 64 Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Sun Pharma 2017-2018 64 Table Lunan Pharma Company Profile 64 Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Lunan Pharma 66 Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Lunan Pharma 2017-2018 66 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions (M USD) 2019-2025 67 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Regions (2019-2025) 67 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Regions in 2025 68 Figure North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast (2019-2025) (M USD) 68 Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast (2019-2025) (M USD) 69 Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast (2019-2025) (M USD) 70 Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast (2019-2025) (M USD) 71 Figure Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast (2019-2025) (M USD) 72 Figure India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast (2019-2025) (M USD) 73 Figure South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast (2019-2025) (M USD) 74 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Product (2019-2025) (M USD) 74 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Product (2019-2025) 75 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Product in 2025 75 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2019-2025) (M USD) 76 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2019-2025) 76 Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application in 2025 77 Table Research Programs/Design for This Report 79 Figure Bottom-up and Top-down Approaches for This Report 81 Figure Data Triangulation 82 Table Key Data Information from Secondary Sources 83 Table Key Data Information from Primary Sources 84

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

We respect your privacy and do not tolerate spam and will never sell, rent or lease your information away.

We respect your privacy and do not tolerate spam and will never sell, rent or lease your information away.

Our Clients

Contact Us
Call Now